Hypouricämie
Unter Hypourikämie werden Störungen des Uratstoffwechsels zusammengefasst, die mit einem erniedrigten Harnsäurespiegel einhergehen.
Gliederung
![]() |
||||||
![]() |
![]() | |||||
![]() |
![]() | |||||
![]() |
![]() |
![]() | ||||
![]() |
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() | |||||
![]() |
![]() | |||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Referenzen:
1. |
Stibůrková B et. al. (2003) Familial juvenile hyperuricaemic nephropathy (FJHN): linkage analysis in 15 families, physical and transcriptional characterisation of the FJHN critical region on chromosome 16p11.2 and the analysis of seven candidate genes. [^] |
2. |
Zivná M et. al. (2009) Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure. [^] |
3. |
Stibůrková B et. al. (2000) Familial juvenile hyperuricemic nephropathy: localization of the gene on chromosome 16p11.2-and evidence for genetic heterogeneity. [^] |
4. |
Hart TC et al. (2002) Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. [^] |
5. |
Turner JJ et. al. (2003) UROMODULIN mutations cause familial juvenile hyperuricemic nephropathy. [^] |
6. |
Rampoldi L et al. (2003) Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. [^] |
7. |
Vylet'al P et. al. (2006) Alterations of uromodulin biology: a common denominator of the genetically heterogeneous FJHN/MCKD syndrome. [^] |
8. |
McBride MB et. al. (1998) Presymptomatic detection of familial juvenile hyperuricaemic nephropathy in children. [^] |
9. |
Zoref-Shani E et al. (2000) Kelley-Seegmiller syndrome due to a unique variant of hypoxanthine-guanine phosphoribosyltransferase: reduced affinity for 5-phosphoribosyl-1-pyrophosphate manifested only at low, physiological substrate concentrations. [^] |
10. |
Gartler SM et. al. (1975) Half chromatid mutations: transmission in humans? [^] |
11. |
Srivastava T et al. (2002) Childhood hyperuricemia and acute renal failure resulting from a missense mutation in the HPRT gene. [^] |
12. |
Francke U et al. (1976) The occurrence of new mutants in the X-linked recessive Lesch-Nyhan disease. [^] |
13. |
LESCH M et al. (1964) A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION. [^] |
14. |
HOEFNAGEL D et al. (1965) HEREDITARY CHOREOATHETOSIS, SELF-MUTILATION AND HYPERURICEMIA IN YOUNG MALES. [^] |
15. |
Francke U et. al. (1977) Answer to criticism of Morton and Lalouel. [^] |
16. |
Wilson JM et. al. (1986) A molecular survey of hypoxanthine-guanine phosphoribosyltransferase deficiency in man. [^] |
17. |
Kelley WN et al. (1967) A specific enzyme defect in gout associated with overproduction of uric acid. [^] |
18. |
Nabholz M et. al. (1969) Genetic analysis with human--mouse somatic cell hybrids. [^] |
19. |
McDonald JA et al. (1971) Lesch-Nyhan syndrome: altered kinetic properties of mutant enzyme. [^] |
20. |
Silvers DN et. al. (1972) Detection of heterozygote in Lesch-Nyhan disease by hair-root analysis. [^] |
21. |
Migeon BR et. al. (1968) X-linked hypoxanthine-guanine phosphoribosyl transferase deficiency: heterozygote has two clonal populations. [^] |
22. |
Yü TF et al. (1972) Rarity of X-linked partial hypoxanthine-guanine phosphoribosyltransferase deficiency in a large gouty population. [^] |
23. |
Nyhan WL et al. (1970) Hemizygous expression of glucose-6-phosphate dehydrogenase in erythrocytes of heterozygotes for the Lesch-Nyhan syndrome. [^] |
24. |
Greene ML et. al. (1970) Hypoxanthine-guanine phosphoribosyltransferase deficiency and Xg blood group. [^] |
25. |
Henderson JF et al. (1969) Inheritance of purine phosphoribosyltransferases in man. [^] |
26. |
Seegmiller JE et. al. (1967) Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. [^] |
27. |
Rosenbloom FM et. al. (1967) Inherited disorder of purine metabolism. Correlation between central nervous system dysfunction and biochemical defects. [^] |
28. |
Lloyd KG et. al. (1981) Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. [^] |
29. |
Strauss GH et. al. (1980) An enumerative assay of purine analogue resistant lymphocytes in women heterozygous for the Lesch-Nyhan Mutation. [^] |
30. |
Ernst M et al. (1996) Presynaptic dopaminergic deficits in Lesch-Nyhan disease. [^] |
31. |
Nyhan WL et al. (1996) New approaches to understanding Lesch-Nyhan disease. [^] |
32. |
Wong DF et. al. (1996) Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. [^] |
33. |
Morton NE et al. (1977) Genetic epidemiology of Lesch-Nyhan disease. [^] |
34. |
None (1977) A probable sex difference in some mutation rates. [^] |
35. |
Graham GW et. al. (1996) Prenatal diagnosis by enzyme analysis in 15 pregnancies at risk for the Lesch-Nyhan syndrome. [^] |
36. |
Dehghan A et. al. (2008) Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. [^] |
37. |
Matsuo H et. al. (2009) Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. [^] |
38. |
Döring A et. al. (2008) SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. [^] |
39. |
Vitart V et. al. (2008) SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. [^] |
40. |
Matsuo H et. al. (2008) Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. [^] |
41. |
Martinon F et. al. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. [^] |
42. |
Hodanová K et. al. (2005) Mapping of a new candidate locus for uromodulin-associated kidney disease (UAKD) to chromosome 1q41. [^] |
43. |
Cameron JS et. al. (1990) Precocious familial gout. [^] |
44. |
Van Goor W et. al. (1971) An unusual form of renal disease associated with gout and hypertension. [^] |
45. |
Leumann EP et. al. (1983) Familial nephropathy with hyperuricemia and gout. [^] |
46. |
Massari PU et. al. (1980) Familial hyperuricemia and renal disease. [^] |
47. |
Simmonds HA et. al. (1980) Familial gout and renal failure in young women. [^] |
48. |
Saeki A et. al. (1995) Newly discovered familial juvenile gouty nephropathy in a Japanese family. [^] |
49. |
McBride MB et. al. (1997) Familial renal disease or familial juvenile hyperuricaemic nephropathy? [^] |
50. |
Kamatani N et. al. (2000) Localization of a gene for familial juvenile hyperuricemic nephropathy causing underexcretion-type gout to 16p12 by genome-wide linkage analysis of a large family. [^] |
51. |
Fairbanks LD et. al. (2002) Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease. [^] |
52. |
Stacey JM et. al. (2003) Genetic mapping studies of familial juvenile hyperuricemic nephropathy on chromosome 16p11-p13. [^] |
53. |
DUNCAN H et. al. (1960) Gout, familial hypericaemia, and renal disease. [^] |
54. |
Dahan K et. al. (2003) A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. [^] |
55. |
Zaucke F et. al. (2010) Uromodulin is expressed in renal primary cilia and UMOD mutations result in decreased ciliary uromodulin expression. [^] |
56. |
Bernascone I et. al. (2010) A transgenic mouse model for uromodulin-associated kidney diseases shows specific tubulo-interstitial damage, urinary concentrating defect and renal failure. [^] |
57. |
Piret SE et. al. (2011) Genome-wide study of familial juvenile hyperuricaemic (gouty) nephropathy (FJHN) indicates a new locus, FJHN3, linked to chromosome 2p22.1-p21. [^] |
58. |
Frank M et. al. (1979) Familial renal hypouricaemia: two additional cases with uric acid lithiasis. [^] |
59. |
Bakay B et. al. (1979) Utilization of purines by an HPRT variant in an intelligent, nonmutilative patient with features of the Lesch-Nyhan syndrome. [^] |
60. |
Benjamin D et. al. (1978) Familial hypouricemia due to isolated renal tubular abnormality. [^] |
61. |
Upchurch KS et. al. (1975) Hypoxanthine phosphoribosyltransferase deficiency: association of reduced catalytic activity with reduced levels of immunologically detectable enzyme protein. [^] |
62. |
Ghangas GS et. al. (1975) Radioimmune determination of hypoxanthine phosphoribosyltransferase crossreacting material in erythrocytes of Lesch-Nyhan patients. [^] |
63. |
Akaoka I et. al. (1975) Familial hypouricaemia due to renal tubular defect of urate transport. [^] |
64. |
Yukawa T et al. (1992) A female patient with Lesch-Nyhan syndrome. [^] |
65. |
Moro F et. al. (1991) Does allopurinol affect the progression of familial juvenile gouty nephropathy? [^] |
66. |
Yokota N et. al. (1991) Autosomal dominant transmission of gouty arthritis with renal disease in a large Japanese family. [^] |
67. |
Moro F et. al. (1991) Familial juvenile gouty nephropathy with renal urate hypoexcretion preceding renal disease. [^] |
68. |
Sanberg PR et. al. (1990) Neural basis of behavior: animal models of human conditions. [^] |
69. |
Gafter U et. al. (1989) Hypouricemia due to familial isolated renal tubular uricosuria. Evaluation with the combined pyrazinamide-probenecid test. [^] |
70. |
Page T et. al. (1987) Syndrome of mild mental retardation, spastic gait, and skeletal malformations in a family with partial deficiency of hypoxanthine-guanine phosphoribosyltransferase. [^] |
71. |
Andrés A et al. (1987) Partial deficit of hypoxanthine guanine phosphoribosyl transferase presenting as acute renal failure. [^] |
72. |
Takeda E et. al. (1985) Hereditary renal hypouricemia in children. [^] |
73. |
van der Zee SP et. al. (1968) Megaloblastic anaemia in the Lesch-Nyhan syndrome. [^] |
74. |
Fujimoto WY et. al. (1968) Biochemical diagnosis of an X-linked disease in utero. [^] |
75. |
Khachadurian AK et. al. (1973) Hypouricemia due to renal uricosuria. A case study. [^] |
76. |
Albertini RJ et. al. (1973) Somatic cell mutation. Detection and quantification of x-ray-induced mutation in cultured, diploid human fibroblasts. [^] |
77. |
Greene ML et. al. (1972) Hypouricemia due to isolated renal tubular defect. Dalmatian dog mutation in man. [^] |
78. |
Boyle JA et al. (1970) Lesch-Nyhan syndrome: preventive control by prenatal diagnosis. [^] |
79. |
Gibbs DA et. al. (1984) First-trimester diagnosis of Lesch-Nyhan syndrome. [^] |
80. |
Harkness RA et. al. (1983) Xanthine oxidase deficiency and 'Dalmatian' hypouricaemia: incidence and effect of exercise. [^] |
81. |
Shichiri M et. al. (1982) Hypouricemia due to an increment in renal tubular urate secretion. [^] |
82. |
Weitz R et. al. (1980) Hereditary renal hypouricemia. Isolated tubular defect of urate reabsorption. [^] |
83. |
Hedley JM et. al. (1980) Familial hypouricaemia associated with renal tubular uricosuria and uric acid calculi: case report. [^] |
84. |
Jinnah HA et. al. (1994) Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. [^] |
85. |
Nyhan WL et al. (1997) The recognition of Lesch-Nyhan syndrome as an inborn error of purine metabolism. [^] |
86. |
Enomoto A et. al. (2002) Molecular identification of a renal urate anion exchanger that regulates blood urate levels. [^] |
87. |
Tanaka M et. al. (2003) Two male siblings with hereditary renal hypouricemia and exercise-induced ARF. [^] |
88. |
Ichida K et. al. (2008) Age and origin of the G774A mutation in SLC22A12 causing renal hypouricemia in Japanese. [^] |
89. |
Hladnik U et al. (2008) Variable expression of HPRT deficiency in 5 members of a family with the same mutation. [^] |
90. |
Ceballos-Picot I et. al. (2009) Hypoxanthine-guanine phosphoribosyl transferase regulates early developmental programming of dopamine neurons: implications for Lesch-Nyhan disease pathogenesis. [^] |
91. |
Cristini S et. al. (2010) Human neural stem cells: a model system for the study of Lesch-Nyhan disease neurological aspects. [^] |
92. |
Sarafoglou K et. al. (2010) Lesch-Nyhan variant syndrome: variable presentation in 3 affected family members. [^] |
93. |
Fu R et. al. (2015) Clinical severity in Lesch-Nyhan disease: the role of residual enzyme and compensatory pathways. [^] |
94. |
None (1979) Genetics of hyperuricemia in families with gout. [^] |
95. |
Healey LA et. al. (1967) Hyperuricemia in Filipinos: interaction of heredity and environment. [^] |
96. |
HAUGE M et. al. (1955) Heredity in gout and hyperuricemia. [^] |
97. |
None (1960) Heredity in primary gout. [^] |
98. |
NEEL JV et. al. (1965) STUDIES ON HYPERURICEMIA. II. A RECONSIDERATION OF THE DISTRIBUTION OF SERUM URIC ACID VALUES IN THE FAMILIES OF SMYTH, COTTERMAN, AND FREYBERG. [^] |
99. |
Cheng LS et. al. (2004) Genomewide scan for gout in taiwanese aborigines reveals linkage to chromosome 4q25. [^] |
100. |
Woodward OM et. al. (2011) ABCG transporters and disease. [^] |
101. |
Köttgen A et. al. (2013) Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. [^] |
102. |
Belostotsky R et. al. (2011) Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome. [^] |
103. |
Sulem P et. al. (2011) Identification of low-frequency variants associated with gout and serum uric acid levels. [^] |